When applied to facial skin, does estrogen ointment have systemic effects?

Arch Gynecol Obstet. 1993;253(2):71-4. doi: 10.1007/BF02768732.

Abstract

We examined cytological vaginal smears of 17 women before and after three months of dermal estrogen (1 g of 0.01% estradiol ointment or 0.3% estriol ointment once daily), applied to the face for dermatological indications. The mean age was 57.1 +/- 7.6 years (range from 46 to 66). Seven women had estrogenic smears (more than 10% superficial cells) before therapy. Nine women were treated with 0.01% estradiol ointment and 8 were treated with 0.3% estriol ointment. Both groups had gynecological examinations including cervical and vaginal smears before and after treatment and also monthly measurements of serum follicle-stimulating hormone, prolactin and estradiol levels. Serum hormone levels and the appearance of vaginal smears showed no significant change during treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Climacteric / blood
  • Climacteric / drug effects*
  • Estradiol / administration & dosage
  • Estradiol / pharmacokinetics*
  • Estriol / administration & dosage
  • Estriol / pharmacokinetics*
  • Female
  • Gonadal Steroid Hormones / blood
  • Humans
  • Middle Aged
  • Ointments
  • Skin Absorption / physiology*
  • Skin Aging / drug effects*
  • Vaginal Smears

Substances

  • Gonadal Steroid Hormones
  • Ointments
  • Estradiol
  • Estriol